Loading
Latest filing published 19 Jan 2021 for Hansa Biopharma AB, €5,492. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Only one filing by Petrus Lindh is known so far (19 January 2021): an open-market purchase, €5,492, in Hansa Biopharma AB. That is too little to draw conclusions. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration